Analysts’ Downgrades for January, 5th (CHFS, CROX, CRVS, CTO, CVA, CYBE, DITHF, DLHC, DTCGF, DYNT)

Analysts’ downgrades for Friday, January 5th:

Sunshine Heart (NASDAQ:CHFS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “CHF Solutions, Inc. is a medical device company which focused on commercializing the Aquadex FlexFlow (R) System. Its commercial product Aquadex system, is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. CHF Solutions Inc., formerly known as Sunshine Heart Inc., is headquartered in Minneapolis. “

Crocs (NASDAQ:CROX) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Crocs, Inc. is a world leader in innovative casual footwear for men, women and children. Crocs offers a broad portfolio of all-season products, while remaining true to its core molded footwear heritage. All Crocs™ shoes feature Croslite™ material, a proprietary, revolutionary technology that gives each pair of shoes the soft, comfortable, lightweight, non-marking and odor-resistant qualities that Crocs fans have known and love. Crocs celebrates the fun of being a little different and encourages fans to Find Your Fun in every colorful pair of shoes. Crocs has sold more than 300 million pairs of shoes in more than 90 countries around the world. “

Corvus Pharmaceuticals (NASDAQ:CRVS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Corvus Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of immuno-oncology therapies to harness the immune system to attack cancer cells. Its products include CPI-444, Adenosine production inhibitor, Adenosine A2B antagonist and Interleukin-2 (IL-2)-inducible T cell kinase (ITK) inhibitors. Corvus Pharmaceuticals, Inc. is based in Burlingame, California. “

Consolidated-Tomoka Land (NYSEAMERICAN:CTO) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Consolidated-Tomoka Land Co. is primarily engaged in the real estate industry through its wholly owned subsidiaries. Real estate operations include commercial real estate, real estate development, residential and golf operations, property leasing, leasing properties for oil and mineral exploration and the sale of forest products. “

Covanta (NYSE:CVA) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Covanta Holding Corporation is an internationally recognized owner and operator of large-scale Energy-from-Waste and renewable energy projects and a recipient of the Energy Innovator Award from the U.S. Department of Energy’s Office of Energy Efficiency and Renewable Energy. Covanta’s Energy-from-Waste facilities provide communities with an environmentally sound solution to their solid waste disposal needs by using that municipal solid waste to generate clean, renewable energy. “

CyberOptics (NASDAQ:CYBE) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “CyberOptics Corporation is a leading provider of sensors and inspection systems that provide process yield and through-put improvement solutions for the global electronic assembly and semiconductor capital equipment markets. The Company’s products are deployed on production lines that manufacture surface mount technology circuit boards and semiconductor process equipment. By increasing productivity and product quality, our sensors and inspection systems enable electronics manufacturers to strengthen their competitive positions in highly price-sensitive markets. Headquartered in Minneapolis, Minnesota, they conduct worldwide operations through facilities in North America, Asia and Europe. “

SMITH(DS) (OTCMKTS:DITHF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “DS Smith Plc is a manufacturer of corrugated products primarily in Europe. The company’s division consists of paper, plastics, packaging and recycling. DS Smith Plc is headquartered in London, the United Kingdom. “

DLH (NASDAQ:DLHC) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “DLH Holdings Corp. serves clients throughout the United States as a full-service provider of healthcare, logistics, and technical support services to DoD and Federal agencies. Its healthcare delivery solutions include professional services, such as case management, health and injury assessment, critical care, medical/surgical, emergency room/trauma center, counseling, behavioral health and trauma brain injury, medical systems analysis, and medical logistics, and allied support services in the areas of MRI technology, diagnostic sonography, phlebotomy, dosimetry, physical therapy, and pharmaceuticals. The company’s logistics and technical services include program and project management, systems engineering and applicable information technology services, integrated logistics support, training, equipment and non-tactical vehicle operations and maintenance, and facilities and shipyard support services. DLH Holdings Corp., formerly known as TeamStaff, Inc., is headquartered in Atlanta, Georgia. “

Dometic Group (OTCMKTS:DTCGF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Dometic Group AB provides branded solutions for mobile living in the areas of Climate, Hygiene & Sanitation and Food & Beverage. It offers products for use in recreational vehicles, trucks and premium cars, pleasure and workboats and for a variety of other uses. The company operates primarily in the Americas, EMEA and Asia Pacific. Dometic Group AB is headquartered in Solna, Sweden. “

Dynatronics (NASDAQ:DYNT) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “DYNATRONICS CORP. is involved in the design, manufacture and sale of medical devices for therapeutic use by medical practitioners. “

EnSync (NYSEAMERICAN:ESNC) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “EnSync, Inc. is a technology solutions company. It develops, licenses and manufactures energy management systems solutions. Its energy storage solutions are based upon zinc bromide rechargeable electrical energy storage technology and power electronics systems. The Company also offers systems which form various levels of micro-grids, hybrid vehicle control systems and power quality regulation solutions. In addition, the Company develops and commercializes energy management systems for off-grid applications. It serves utility, commercial and industrial building and off-grid markets. EnSync, Inc., formerly known as ZBB Energy Corporation, is headquartered in Menomonee Falls, Wisconsin. “

Receive News & Ratings for Sunshine Heart Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sunshine Heart Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply